semaglutide aion Use of and risk of non‐arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study - Simonsen - 2025 - Diabetes, Obesity and Metabolism Semaglutide and Nonarteritic Anterior Ischemic

Since approximately 5-10% of users experience dry mouth during treatment, staying vigilant about symptoms and discussing concerns with healthcare professionals helps guarantee appropriate management strategies can be implemented early, helping maintain oral comfort while continuing necessary medication

Most, but not all, of these patients who reported this adverse effect had underlying anatomic or vascular risk factors for development of NAION

Once you agree to the procedure, we can start your weight loss journey with Semaglutide The treatment requires a weekly dosage that is in a single-use injection pen, much like insulin injections for diabetes

Catch problems early

doi: 10.1038/s41591-025-03774-9 182 GruberTLechnerFKriegerJPGarca-CceresC

The report highlights the financial success of Monjaro but does not address the affordability and accessibility of the drug for patients, which can be a significant issue in healthcare